Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1982 May 1;126(9):1041–1046.

Cyclosporin A: a powerful immunosuppressant.

A Laupacis, P A Keown, R A Ulan, N McKenzie, C R Stiller
PMCID: PMC1863293  PMID: 7074504

Abstract

Cyclosporin A (CyA) is a powerful immunosuppressive agent whose lack of myelotoxicity makes it unique among nonsteroidal drugs currently given for immunosuppression. It has been used with initial success in recipients of kidney, liver, bone marrow and pancreas transplants, and it may also have clinical application in the treatment of autoimmune disorders. In regard to its use in transplant recipients, there are many remaining questions about its mechanism of action, the optimum dose, whether it should be used alone or with other immunosuppressants, whether it can suppress chronic rejection and what its long-term side effects may be. These questions can only be answered by further careful laboratory investigation and controlled clinical trials. Until then, CyA should only be administered in centres experienced in its use.

Full text

PDF
1041

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borel J. F., Feurer C., Magnée C., Stähelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology. 1977 Jun;32(6):1017–1025. [PMC free article] [PubMed] [Google Scholar]
  2. Calne R. Y., Rolles K., White D. J., Thiru S., Evans D. B., Henderson R., Hamilton D. L., Boone N., McMaster P., Gibby O. Cyclosporin-A in clinical organ grafting. Transplant Proc. 1981 Mar;13(1 Pt 1):349–358. [PubMed] [Google Scholar]
  3. Crawford D. H., Sweny P., Edwards J. M., Janossy G., Hoffbrand A. V. Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet. 1981 Jan 3;1(8210):10–12. doi: 10.1016/s0140-6736(81)90115-x. [DOI] [PubMed] [Google Scholar]
  4. Deeg H. J., Storb R., Gerhard-Miller L., Shulman H. M., Weiden P. L., Thomas E. D. Cyclosporin A, a powerful immunosuppressant in vivo and in vitro in the dog, fails to induce tolerance. Transplantation. 1980 Mar;29(3):230–235. doi: 10.1097/00007890-198003000-00014. [DOI] [PubMed] [Google Scholar]
  5. Gratwohl A., Forster I., Speck B. Skin grafts in rabbits with cyclosporin A: absence of induction of tolerance and untoward side effects. Transplantation. 1981 Feb;31(2):136–138. doi: 10.1097/00007890-198102000-00011. [DOI] [PubMed] [Google Scholar]
  6. Green C. J. Immunosuppression with cyclosporin A: a review. Diagn Histopathol. 1981 Apr-Jun;4(2):157–174. [PubMed] [Google Scholar]
  7. Hamilton D. V., Calne R. Y., Evans D. B., Henderson R. G., Thiru S., White D. J. The effect of long-term cyclosporin A on renal function. Lancet. 1981 May 30;1(8231):1218–1219. doi: 10.1016/s0140-6736(81)92392-8. [DOI] [PubMed] [Google Scholar]
  8. Homan W. P., Fabre J. W., Williams K. A., Millard P. R., Morris P. J. Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts. Transplantation. 1980 May;29(5):361–366. doi: 10.1097/00007890-198005000-00003. [DOI] [PubMed] [Google Scholar]
  9. Homan W. P., French M. E., Millard P. R., Morris P. J. A study of eleven drug regimens using cyclosporin-A to suppress renal allograft rejection in the dog. Transplant Proc. 1981 Mar;13(1 Pt 1):397–401. [PubMed] [Google Scholar]
  10. Homan W. P., French M. E., Millard P., Denton T. G., Fabre J. W., Morris P. J. Studies on the effects of cyclosporin A upon renal allograft rejection in the dog. Surgery. 1980 Jul;88(1):168–173. [PubMed] [Google Scholar]
  11. Introna M., Allavena P., Spreafico F., Mantovani A. Inhibition of human natural killer activity by cyclosporin A. Transplantation. 1981 Feb;31(2):113–116. doi: 10.1097/00007890-198102000-00004. [DOI] [PubMed] [Google Scholar]
  12. Isenberg D. A., Snaith M. L., Al-Khader A. A., Cohen S. L., Fisher C., Morrow W. J., Mowbray J. Cyclosporin relieves arthralgia, causes angioedema. N Engl J Med. 1980 Sep 25;303(13):754–754. doi: 10.1056/NEJM198009253031312. [DOI] [PubMed] [Google Scholar]
  13. Keown P. A., Stiller C. R., Ulan R. A., Sinclair N. R., Wall W. J., Carruthers G., Howson W. Immunological and pharmacological monitoring in the clinical use of cyclosporin A. Lancet. 1981 Mar 28;1(8222):686–689. doi: 10.1016/s0140-6736(81)91971-1. [DOI] [PubMed] [Google Scholar]
  14. Keown P. A., Stiller C. R., Ulan R. A. Use of cyclosporin a despite renal dysfunction. N Engl J Med. 1981 Jul 23;305(4):227–228. doi: 10.1056/NEJM198107233050421. [DOI] [PubMed] [Google Scholar]
  15. Leapman S. B., Filo R. S., Smith E. J., Smith P. G. Differential effects of cyclosporin-A on lymphocyte subpopulations. Transplant Proc. 1981 Mar;13(1 Pt 1):405–409. [PubMed] [Google Scholar]
  16. Leapman S. B., Filo R. S., Smith E. J., Smith P. G. In vitro effects of cyclosporin A on lymphocyte subpopulations. 1. Suppressor cell sparing by cyclosporin A. Transplantation. 1980 Dec;30(6):404–408. doi: 10.1097/00007890-198012000-00003. [DOI] [PubMed] [Google Scholar]
  17. McMaster P., Gibby O. M., Calne R. Y., Loke M., Luzio S. D., Rolles K., White D. J., Evans D. B. Human pancreatic transplantation--preliminary studies of carbohydrate control. Transplant Proc. 1981 Mar;13(1 Pt 1):371–373. [PubMed] [Google Scholar]
  18. Mueller W., Herrmann B. Cyclosporin A for psoriasis. N Engl J Med. 1979 Sep 6;301(10):555–555. doi: 10.1056/NEJM197909063011016. [DOI] [PubMed] [Google Scholar]
  19. Powles R. L., Clink H. M., Spence D., Morgenstern G., Watson J. G., Selby P. J., Woods M., Barrett A., Jameson B., Sloane J. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet. 1980 Feb 16;1(8164):327–329. doi: 10.1016/s0140-6736(80)90881-8. [DOI] [PubMed] [Google Scholar]
  20. Routhier G., Epstein O., Janossy G., Thomas H. C., Sherlock, Kung P. C., Goldstein G. Effects of cyclosporin A on suppressor and inducer T lymphocytes in primary biliary cirrhosis. Lancet. 1980 Dec 6;2(8206):1223–1226. doi: 10.1016/s0140-6736(80)92481-2. [DOI] [PubMed] [Google Scholar]
  21. Shulman H., Striker G., Deeg H. J., Kennedy M., Storb R., Thomas E. D. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury. N Engl J Med. 1981 Dec 3;305(23):1392–1395. doi: 10.1056/NEJM198112033052306. [DOI] [PubMed] [Google Scholar]
  22. Starzl T. E., Klintmalm G. B., Porter K. A., Iwatsuki S., Schröter G. P. Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med. 1981 Jul 30;305(5):266–269. doi: 10.1056/NEJM198107303050507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Starzl T. E., Weil R., 3rd, Iwatsuki S., Klintmalm G., Schröter G. P., Koep L. J., Iwaki Y., Terasaki P. I., Porter K. A. The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet. 1980 Jul;151(1):17–26. [PMC free article] [PubMed] [Google Scholar]
  24. Sweny P., Farrington K., Younis F., Varghese Z., Baillod R. A., Fernando O. N., Moorhead J. F. Sixteen months experience with cyclosporin-A in human kidney transplantation. Transplant Proc. 1981 Mar;13(1 Pt 1):365–367. [PubMed] [Google Scholar]
  25. Thiru S., Calne R. Y., Nagington J. Lymphoma in renal allograft patients treated with cyclosporin-A as one of the immunosuppressive agents. Transplant Proc. 1981 Mar;13(1 Pt 1):359–364. [PubMed] [Google Scholar]
  26. Tutschka P. J., Beschorner W. E., Allison A. C., Burns W. H., Santos G. W. Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature. 1979 Jul 12;280(5718):148–151. doi: 10.1038/280148a0. [DOI] [PubMed] [Google Scholar]
  27. White D. J., Timmerman W., Davies H. S., Nagao T., Kasahara K., Plumb A. Properties of cyclosporin--A-induced graft acceptance. Transplant Proc. 1981 Mar;13(1 Pt 1):379–382. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES